LINC01116 drove oncogenic phenotypes in NSCLC by activating RNA polymerase I transcription [22], reducing IFI44 expression [23], and targeting the miR-9-5p/CCNE1 axis [24]. Here, LINC01116 is linked to non-small cell lung carcinoma.